Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells

Nature Immunology

Volumn 14, Issue 1, 2013, Pages 90-99

  Cohen, Nadia R ^a   Brennan, Patrick J ^a   Shay, Tal ^b   Watts, Gerald F ^a   Brigl, Manfred ^a   Kang, Joonsoo ^c   Brenner, Michael B ^a   Monach, Paul ^d   Shinton, Susan A ^d   Hardy, Richard R ^e   Jianu, Radu ^e   Koller, David ^f   Collins, Jim ^g   Gazit, Roi ^g   Garrison, Brian S ^g   Rossi, Derrick J ^c   Narayan, Kavitha ^f   Sylvia, Katelyn ^c   Fletcher, Anne ^h   Elpek, Kutlu ^h   Bellemare Pelletier, Angelique ^h   Malhotra, Deepali ^h   Turley, Shannon ^h   Best, Adam J ⁱ   Knell, Jamie ⁱ   Goldrath, Ananda ⁱ   Jojic, Vladimir ^j   Koller, Daphne ^j   Regev, Aviv ^k   Cohan, Nadia ^b   Brennen, Patrick ^b   Brennar, Michael ^b   Kreslavsky, Taras ^h   Bezman, Natalie A ^a   Sun, Joseph C ^a   Kim, Charlie C ^a   Lanier, Lewis L ^a   Miller, Jennifer ^l   Brown, Brian ^l   Merad, Miriam ^l   Gautier, Emmanuel L ^l,m   Jakubzick, Claudia ^l   Randolph, Gwendalyn J ^m,n   Kim, Francis ^o   Rao, Tata Nageswara ^o   Wagers, Amy ^o   Heng, Tracy ⁱ   Painter, Michio ⁱ   Ericson, Jeffrey ⁱ   Davis, Scott ⁱ   Ergun, Ayla ⁱ   Mingueneau, Michael ⁱ   Mathis, Diane ⁱ   Benoist, Christophe ⁱ   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f Brown Univerity   (United States)

^g Boston University   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^k Stanford University   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁿ WASHINGTON UNIVERSITY   (United States)

^o JOSLIN DIABETES CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; CELL POPULATION; GAMMA DELTA T LYMPHOCYTE; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; GENOME, HUMAN; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; MICE; MICROARRAY ANALYSIS; NATURAL KILLER T-CELLS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TRANSCRIPTOME;

EID: 84871181695     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2490     Document Type: Article

References (57)

1. Heng, T.S.P. et al. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091-1094 (2008).
2. Cohen, N.R., Garg, S. & Brenner, M.B. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv. Immunol. 102, 1-94 (2009).
3. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
4. Godfrey, D.I., Stankovic, S. & Baxter, A.G. Raising the NKT cell family. Nat. Immunol. 11, 197-206 (2010).
5. Coquet, J.M. et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc. Natl. Acad. Sci. USA 105, 11287-11292 (2008).
6. Cerundolo, V., Silk, J.D., Masri, S.H. & Salio, M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9, 28-38 (2009).
7. Makino, Y., Kanno, R., Ito, T., Higashino, K. & Taniguchi, M. Predominant expression of invariant Vα14+ TCR α chain in NK1.1+ T cell populations. Int. Immunol. 7, 1157-1161 (1995).
8. Bendelac, A. Mouse NK1+ T cells. Curr. Opin. Immunol. 7, 367-374 (1995).
9. Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J. & Van Kaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231-237 (2004).
10. Grégoire, C. et al. The trafficking of natural killer cells. Immunol. Rev. 220, 169-182 (2007).
11. Matsuda, J.L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
12. Cooper, M.A. et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100, 3633-3638 (2002).
13. Matsuda, J.L. et al. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 3, 966-974 (2002).
14. Brigl, M. & Brenner, M.B. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Semin. Immunol. 22, 79-86 (2010).
15. Lanier, L.L. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8, 259-268 (2008).
16. Kuylenstierna, C. et al. NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur. J. Immunol. 41, 1913-1923 (2011).
17. Kawamura, T. et al. NKG2A inhibits invariant NKT cell activation in hepatic injury. J. Immunol. 182, 250-258 (2009).
18. Maeda, M., Lohwasser, S., Yamamura, T. & Takei, F. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J. Immunol. 167, 4180-4186 (2001).
19. Ota, T. et al. IFN-γ-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood 106, 184-192 (2005).
20. Brennan, P.J. et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat. Immunol. 12, 1202-1211 (2011).
21. Paget, C. et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27, 597-609 (2007).
22. Salio, M. et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc. Natl. Acad. Sci. USA 104, 20490-20495 (2007).
23. Reschner, A., Hubert, P., Delvenne, P., Boniver, J. & Jacobs, N. Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin. Exp. Immunol. 152, 219-226 (2008).
24. Andrews, D.M., Scalzo, A.A., Yokoyama, W.M., Smyth, M.J. & Degli-Esposti, M.A. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4, 175-181 (2003).
25. Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237 (2003).
26. Fernandez, N.C. et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5, 405-411 (1999).
27. Vincent, M.S. et al. CD1-dependent dendritic cell instruction. Nat. Immunol. 3, 1163-1168 (2002).
28. Walzer, T., Dalod, M., Vivier, E. & Zitvogel, L. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin. Biol. Ther. 5 Suppl 1, S49-S59 (2005).
29. Savage, A.K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391-403 (2008).
30. Kovalovsky, D. et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9, 1055-1064 (2008).
31. Yu, S. & Cantorna, M.T. The vitamin D receptor is required for iNKT cell development. Proc. Natl. Acad. Sci. USA 105, 5207-5212 (2008).
32. Gumperz, J.E., Miyake, S., Yamamura, T. & Brenner, M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
33. Watarai, H. et al. Development and function of invariant natural killer T cells producing Th2-and Th17-cytokines. PLoS Biol. 10, e1001255 (2012).
34. Crowe, N.Y. et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202, 1279-1288 (2005).
35. Brigl, M. et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208, 1163-1177 (2011).
36. Johnston, B., Kim, C.H., Soler, D., Emoto, M. & Butcher, E.C. Differential chemokine responses and homing patterns of murine TCRαβ NKT cell subsets. J. Immunol. 171, 2960-2969 (2003).
37. Townsend, M.J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20, 477-494 (2004).
38. Thomas, P.D. et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 31, 334-341 (2003).
39. O'Brien, R.L. & Born, W.K., T cell subsets: a link between TCR and function? Semin. Immunol. 22, 193-198 (2010).
40. Fahrer, A.M. et al. Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile. Proc. Natl. Acad. Sci. USA 98, 10261-10266 (2001).
41. Shires, J., Theodoridis, E. & Hayday, A.C. Biological insights into TCRγδ+ and TCRαβ+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 15, 419-434 (2001).
42. Vivier, E. & Anfossi, N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4, 190-198 (2004).
43. Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290-1297 (2011).
44. Matsuda, J.L. et al. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 107, 2797-2805 (2006).
45. Gordy, L.E. et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J. Immunol. 187, 6335-6345 (2011).
46. Kastner, P. et al. Bcl11b represses a mature T-cell gene expression program in immature CD4+CD8+ thymocytes. Eur. J. Immunol. 40, 2143-2154 (2010).
47. Yue, X., Izcue, A. & Borggrefe, T. Essential role of mediator subunit Med1 in invariant natural killer T-cell development. Proc. Natl. Acad. Sci. USA 108, 17105-17110 (2011).
48. Sullivan, B.M., Juedes, A., Szabo, S.J., von Herrath, M. & Glimcher, L.H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100, 15818-15823 (2003).
49. Inagaki-Ohara, K., Nishimura, H., Mitani, A. & Yoshikai, Y. Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice. Eur. J. Immunol. 27, 2885-2891 (1997).
50. Honma, S. et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419, 841-844 (2002).
51. Miyazaki, K. et al. The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells. J. Immunol. 185, 7330-7339 (2010).
52. Sun, H., Lu, B., Li, R.Q., Flavell, R.A. & Taneja, R. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2, 1040-1047 (2001).
53. Weber, B.N. et al. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476, 63-68 (2011).
54. Willinger, T. et al. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J. Immunol. 176, 1439-1446 (2006).
55. Gattinoni, L. et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med. 15, 808-813 (2009).
56. Marshall, H.D. et al. Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4+ cell properties during viral infection. Immunity 35, 633-646 (2011).
57. Huang da, W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).